相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Selective induction of apoptosis of NB4 cells from G2+M phase by sodium arsenite at lower doses
Dong-Chu Ma et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Catalase activity and arsenic sensitivity in acute leukemia
Emma Coe et al.
LEUKEMIA & LYMPHOMA (2008)
Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies
A Panwalkar et al.
CANCER (2004)
ROS stress in cancer cells and therapeutic implications
H Pelicano et al.
DRUG RESISTANCE UPDATES (2004)
Role of NADPH oxidase in arsenic-induced reactive. oxygen species formation and cytotoxicity in myeloid leukemia cells
WC Chou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling
J Yi et al.
CANCER RESEARCH (2004)
In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines
P La Rosee et al.
BLOOD (2004)
Inhibition of mitochondrial respiration - A novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism
H Pelicano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Opportunities for Trisenox® (arsenic trioxide) in the treatment of myelodysplastic syndromes
A List et al.
LEUKEMIA (2003)
Role of Jun and Jun kinase in resistance of cancer cells to therapy
I Vasilevskaya et al.
DRUG RESISTANCE UPDATES (2003)
Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents
Y Zhou et al.
BLOOD (2003)
Arsenic trioxide: Mechanisms of action
K Davison et al.
SEMINARS IN HEMATOLOGY (2002)
Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with its transcription factor partners, including the PML-retinoic acid receptor α oncoprotein found in human acute promyelocytic leukemia
SH Hong et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Cellular stress response and apoptosis in cancer therapy
I Herr et al.
BLOOD (2001)
Arsenic trioxide induces G2/M growth arrest and apoptosis after caspase-3 activation and bcl-2 phosphorylation in promonocytic U937 cells
JW Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells
JM Grad et al.
BLOOD (2001)
The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver
JF DiMartino et al.
BLOOD (2001)
Reactive oxygen species and signal transduction
T Finkel
IUBMB LIFE (2001)
Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis
O Sordet et al.
BLOOD (2001)
Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia:: studies of cytotoxicity, apoptosis and the pattern of resistance
S Lehmann et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2001)
Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo
YK Jing et al.
BLOOD (2001)
Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase
P Kapahi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis
K Kitamura et al.
LEUKEMIA (2000)
分享论文
